According to Cosmo Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 2.61.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 2.06 | -7.46% |
2022-12-31 | 2.23 | 6.97% |
2021-12-31 | 2.08 | -27.04% |
2020-12-31 | 2.85 | 9.52% |
2019-12-31 | 2.61 | 0.09% |
2018-12-31 | 2.60 | -34.69% |
2017-12-31 | 3.99 | -25.73% |
2016-12-31 | 5.37 | 2.32% |
2015-12-31 | 5.24 | -53.61% |
2014-12-31 | 11.3 | 141.97% |
2013-12-31 | 4.67 | 61.91% |
2012-12-31 | 2.89 | |
2011-12-31 | N/A | |
2010-12-31 | N/A | -100% |
2009-12-31 | 2.66 |